Mechanisms of action of paracetamol and related analgesics

Inflammopharmacology

Volumn 11, Issue 4-6, 2003, Pages 401-413

  Graham, Garry G ^a,b   Scott, Kieran F ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Acetaminophen; COX 1; COX 2; COX 3; Dipyrone; Paracetamol; Peroxidase; Prostaglandin; Salicylate

Indexed keywords

ACETYLSALICYLIC ACID; AMINOPHENAZONE; ANALGESIC AGENT; ANTIPYRETIC AGENT; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYCLOOXYGENASE 3; DIPYRONE; DRUG METABOLITE; HYDROPEROXIDE; ISOENZYME; METHYLAMINOPYRINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PEROXIDASE; PHENAZONE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PYRAZOLONE DERIVATIVE; SALICYLATE SODIUM; SALICYLIC ACID; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CONFERENCE PAPER; DIGESTIVE SYSTEM INJURY; DRUG MECHANISM; DRUG SELECTIVITY; ENZYME INHIBITION; HUMAN; INTESTINE INJURY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RHEUMATOID ARTHRITIS; SIDE EFFECT; SODIUM URINE LEVEL;

EID: 0842284230     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856003322699573     Document Type: Conference Paper

References (37)

1. Anderson, B. J., Holford, N. H., Woollard, G. A., et al. (1999). Perioperative pharmacokinetics of acetaminophen analgesia in children, Anesthesiology 90, 411-421.
2. 2 synthases by salicylate is dependent on the oxidative state of the enzymes, J. Pharmacol. Exp. Ther. 304, 589-595.
3. Bannwarth, B., Netter, P., Lapicque, F., et al. (1992). Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol, Br. J. Clin. Pharmacol. 34, 79-81.
4. Bianchi Porro, G., Ardizzone, S., Perrillo, M., et al. (1996). Endoscopic assessment of the effects of dipyrone (metamizol) in comparison to paracetamol and placebo on the gastric and duodenal mucosa of healthy adult volunteers, Digestion 57, 186-190.
5. 2 synthases, Proc. Natl. Acad. Sci. USA 99, 7130-7135.
6. Brune, K. and Peskar, B. A. (1980). Paracetamol does not potentiate the acetylsalicylate inhibition of prostaglandin release from macrophages, Eur. J. Pharmacol. 68, 365-367.
7. Brune, K., Rainsford, K. D., Wagner, K., et al. (1981). Inhibition by anti-inflammatory drugs of prostaglandin production in cultured macrophages, Naunyn-Schmiedeberg's Arch. Pharmacol. 315, 269-278.
8. Chandrasekharan, N. V., Dai, H., Roos, K. L., et al. (2002). COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression, Proc. Natl. Acad. Sci. USA 99, 13926-13931.
9. Cohen, D., Corbin, J., Figueroa, J. P., et al. (1985). Inhibition of arachidonic acid metabolism by antipyrine and 4-aminopyrine, Am. J. Obstet. Gynecol. 153, 589-590.
10. Cryer, B. and Feldman, M. (1998). Cyclooxygenase-1 and cycloxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs, Am. J. Med. 104, 413-421.
11. 2 synthesis in rat microglial cells, Neuropharmacology 39, 2205-2213.
12. Giuliano, F., Mitchell, J. A. and Warner, T. D. (2001). Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial liposaccharide in vivo, J. Pharmacol. Exp. Ther. 299, 894-900.
13. Graham, G. G., Champion, G. D., Day, R. O., et al. (1976). Salicylates in rheumatoid arthritis: pharmacokinetics and analgesic response, Agents Actions Suppl. 1, 37-42.
14. Graham, G. G., Day, R. O., Milligan, M. K., et al. (1999). Current concepts of the actions of paracetamol (acetaminophen) and NSAIDs, Inflammopharmacology 7, 255-263.
15. Graham, G. G., Robins, S.-A., Bryant, K. J., et al. (2001). Inhibition of prostaglandin synthesis in intact cells by paracetamol (acetaminophen), Inflammopharmacology 9, 131-142.
16. 2 synthesis in brain macrophages by inhibiting enzymatic activity of cyclooxygenase but not phospholipase and prostaglandin E synthase, J. Neurosci. Res. 71, 844-852.
17. Landolfi, C., Soldo, L., Polenzani, L., et al. (1998). Inflammatory molecule release by β-amyloid-treated T98G astrocytoma cells: role of prostaglandins and modulation by paracetamol, Eur. J. Pharmacol. 360, 55-64.
18. Lanz, R., Polster, P. and Brune, K. (1986). Antipyretic analgesics inhibit prostaglandin release from astrocytes and macrophages similarly, Eur. J. Pharmacol. 130, 105-109.
19. Levy, M., Zylber-Katz, E. and Rosenkranz, B. (1995). Clinical pharmacokinetics of dipyrone and its metabolites, Clin. Pharmacokinet. 28, 216-414.
20. 2 release in spinal cord slices: relative effect of of cyclooxygenase inhibitors, Eur. J. Pharmacol. 271, 293-299.
21. Mitchell, J. A., Akarasereenont, P., Thiemermann, C., et al. (1994). Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase, Proc. Natl. Acad. Sci. USA 90, 11693-11697.
22. Mitchell, J. A., Saunders, M., Barnes, P. J., et al. (1997). Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor κB) activation: role of arachidonic acid, Mol. Pharmacol. 51, 907-912.
23. 2 synthase that acts in concert with cyclooxygenase-2, J. Biol. Chem. 276, 32783-32792.
24. Ouellet, M. and Percival, M. D. (2001). Mechanism of acetaminophen inhibition of cyclooxygenase isoforms, Arch. Biochem. Biophys. 387, 273-280.
25. Pelissier, T., Alloui, A., Caussade, F., et al. (1996). Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence, J. Pharmacol. Exp. Ther. 278, 8-14.
26. Riendeau, D., Charleson, S., Cromlish, W., et al. (1997). Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays, Can. J. Physiol. Pharmacol. 75, 1088-1095.
27. Sandrini, M., Vitale, G. and Pini, L. A. (2002). Effect of rofecoxib on nociception and the serotonin system in the rat brain, Inflamm. Res. 51, 154-159.
28. Sciulli, M. G., Seta, F., Tacconelli, S., et al. (2003). Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells, Br. J. Pharmacol. 138, 634-641.
29. Shen, J., Wanwimolruk, S., Purves, R. D., et al. (1991). Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose, J. Pharmacokinet. Biopharm. 19, 575-595.
30. Simmons, D. L., Botting, R. M., Robertson, P. M., et al. (1999). Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to non-steroid antiinflammatory drugs, Proc. Natl. Acad. Sci. USA 96, 3275-3280.
31. Smith, W. L. and Song, I. (2002). The enzymology of prostaglandin endoperoxide H synthases-1 and -2, Prostagland Lipid Med. 68-69, 115-128.
32. Szczeklik, A., Gryglewski, R. J. and Czerniawska-Mysik, G. (1977). Clinical patterns of hypersensitivity to nonsteroidal anti-inflammmatory drugs and their pathogenesis, J. Allergy Clin. Immunol. 60, 276-284.
33. Vane, J. R. (1971). Inhibition of prostaglandin synthesis as a mechanism for aspirin-like drugs, Nature New Biol. 66, 232-235.
34. Warner, T. D., Giuliano, F., Vojnovic, I., et al. (1999). Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis, Proc. Natl. Acad. Sci. USA 96, 7563-7568.
35. Weithmann, K. U. and Alpermann, H.-G. (1985). Biochemical and pharmacological effects of dipyrone and its metabolites in model systems related to arachidonic acid cascade, Arzneim. Forsch. 35, 947-952.
36. Wu, K. K., Sanduja, R., Tsai, A.-L., et al. (1991). Aspirin inhibits interleukin-1 prostaglandin H synthase expression in cultured endothelial cells, Proc. Natl. Acad. Sci. USA 88, 2384-2387.
37. Xu, M. M., Sansores-Garcia, L. and Chen, X. M. (1999). Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate, Proc. Natl. Acad. Sci. USA 96, 5292-5297.